Get it on Google Play

Insulet receives FDA clearance for Omnipod 5 algorithm enhancements

December 4, 2025 7:00 AM EST Send to a Friend
Insulet Corporation (NASDAQ: PODD) announced it received FDA 510(k) clearance for enhancements to its Omnipod 5 Automated Insulin Delivery System ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login